Silva Rajiv de's Net Worth
$27.3 Million
Who is Silva Rajiv de?
Silva Rajiv de has an estimated net worth of $27.3 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., Endo International plc, AMAG PHARMACEUTICALS INC., Venus Concept Inc., VALEANT PHARMACEUTICALS INTERNATIONAL, and ENDO HEALTH SOLUTIONS INC..
SEC CIK
Silva Rajiv de's CIK is 0001453140
Past Insider Trading and Trends
2010 was Silva Rajiv de's most active year for acquiring shares with 16 total transactions. Silva Rajiv de's most active month to acquire stocks was the month of January. 2010 was Silva Rajiv de's most active year for disposing of shares, totalling 14 transactions. Silva Rajiv de's most active month to dispose stocks was the month of October. 2010 saw Silva Rajiv de paying a total of $8,570,098.05 for 1,377,137 shares, this is the most they've acquired in one year. In 2012 Silva Rajiv de cashed out on 650,456 shares for a total of $16,126,560.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.05% | -5.45K |
—
|
—
| 259.77K |
Jan 5
| |||
Form 4
|
—
|
0
|
$39.73 | -$2,185,011.09 | 265.22K |
Nov 8
| |||
Form 4
| -0.00% | -2.00 |
$33.14 | -$9,377,731.73 | 265.22K |
Nov 6
| |||
Form 4
| -0.36% | -955.00 |
—
|
—
| 265.22K |
Oct 24
| |||
Form 4
| +21.55% | 47.19K |
—
|
—
| 266.17K |
Sep 26
| |||
Form 4
| -1.04% | -2.29K |
—
|
—
| 218.99K |
Jul 25
| |||
Form 4
| -6.07% | -14.29K |
—
|
—
| 221.28K |
Sep 19 - Sep 23
| |||
Form 4
| -4.99% | -12.36K |
—
|
—
| 235.57K |
Jan 5
| |||
Form 4
| +2.56% | 6.18K |
—
|
—
| 247.94K |
Oct 24
| |||
Form 4
| +2.62% | 6.18K |
$40.40 | $249,665.82 | 241.76K |
Aug 12
| |||
Form 4/A
| +6.72% | 14.84K |
—
|
—
| 235.58K |
Jul 25
| |||
Form 4
| +23.40% | 51.64K |
—
|
—
| 272.38K |
Jul 25
| |||
Form 4
| +12.67% | 51.64K |
$31.65 | -$896,307.46 | 459.41K |
Jun 1 - Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| -40.86% | -201.62K |
$17.56 | -$5,788,992.53 | 291.79K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
∞
| 484.24K |
—
|
—
| 484.24K |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Endo International plc (ENDPQ) Snapshot price: $0.0008
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.43% | -54.89K |
$29.90 | -$1,026,793.14 | 596.1K |
Mar 18 - Mar 21
| |||
Form 4
| +0.91% | 2.25K |
$44.50 | $100,125.00 | 250.71K |
Mar 7
| |||
Form 4
| -2.32% | -15.11K |
$43.06 | -$2,419,885.88 | 635.04K |
Mar 2
| |||
Form 4
| +46.75% | 149.34K |
—
|
—
| 468.77K |
Feb 23
| |||
Form 4
| +5.22% | 9.01K |
$55.52 | $500,013.12 | 181.38K |
Nov 11
| |||
Form 4
| +27.70% | 69.29K |
—
|
—
| 319.42K |
Feb 24
| |||
Form 4
| -3.50% | -6.24K |
$72.90 | -$455,187.60 | 172.37K |
Dec 31
| |||
Form 4
| +52.18% | 85.77K |
—
|
—
| 250.13K |
Sep 2
| |||
Form 4
|
∞
| 419.99K |
—
|
—
| 419.99K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 14.82K |
—
|
—
| 14.82K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Venus Concept Inc. (VERO) Snapshot price: $0.53
Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.25M |
$0.20 | $250,000.00 | 1.25M |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VALEANT PHARMACEUTICALS INTERNATIONAL No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -261.99K |
—
|
—
|
0
|
Sep 28
| |||
Form 4
| -2.47% | -2.39K |
$57.02 | -$136,106.74 | 94.1K |
Aug 24
| |||
Form 4
|
—
|
0
|
$33.96 | -$518,928.30 | 96.49K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -2.17% | -2.14K |
$34.27 | -$73,440.61 | 96.49K |
Jan 21
| |||
Form 4
| +9.13% | 9.01K |
—
|
—
| 107.64K |
Sep 10
| |||
Form 4
| +10.05% | 9.01K |
$24.98 | $224,994.86 | 98.63K |
Aug 24
| |||
Form 4
| +14.86% | 11.6K |
—
|
—
| 89.62K |
Mar 10
| |||
Form 4
| +17.45% | 11.6K |
$17.28 | $200,304.78 | 78.03K |
Feb 27
| |||
Form 4
|
∞
| 66.43K |
—
|
—
| 66.43K |
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||